This article analyzes Bio Protocol's price evolution trajectory from its current $0.05 level toward a $0.50 target by 2030, examining historical volatility patterns, technical support-resistance dynamics, and market correlation factors. The analysis reveals BIO's trading range spans from $0.016835 to $0.1819, with critical resistance at $0.116 and support at $0.044226, establishing realistic expectations for price movements. Current market data shows BIO's market capitalization reaches $95.08 million with 24-hour trading volume of $19.7 million, demonstrating solid ecosystem liquidity. Price trajectory models project potential 461.52% growth toward $0.2779044 by 2032, contingent on successful protocol updates, expanded ecosystem adoption, and favorable regulatory frameworks. Key drivers include increased DeSci adoption, strategic partnerships, enhanced trading volumes, and strengthened investor confidence. The article identifies primary challenges including market volatility, regulatory uncertainty, and compe